StockData
Turning Point Brands, Inc. logo

Turning Point Brands, Inc. (TPB) stock

TPBNYSETobacco ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3061% above fair value
$55.55−0.20 (-0.36%)

Close on Nov 13, 2026Market cap $1.11BP/E 40.0Yield 0.54%

Earnings

Turning Point Brands's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 1, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$151.10M
+27.0% on a year earlier
Adjusted Diluted EPS, Q3 FY2026
$0.41
$1.27 a year earlier
Latest guidance
Issued
Nov 9, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Turning Point Brands's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 1, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026before the open$151.10M+27.0%$0.19$0.41Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026before the open$142.90M+22.6%$0.18$0.23Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open$124.30M+16.8%$0.60$0.76Release
Q4 FY2025ended Dec 31, 2025Mar 2, 2026before the open$121.00M+29.1%$0.42$0.95Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open$119.00M+12.7%$1.13$1.27Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$116.60M+7.5%$0.79$0.98Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open$106.40M+9.6%$0.79$0.91Release
Q4 FY2024ended Dec 31, 2024Mar 6, 2025before the open$93.70M-3.5%$0.13$0.98Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$105.60M+3.8%$0.68$0.87Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024before the open$108.50M+2.7%$0.68$0.89Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$97.10M-3.9%$0.63$0.80Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Turning Point Brands's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Modern Oral Net SalesFY2026$260.00M – $270.00M–NewNov 9, 2026
Modern Oral Net SalesFY2026$260.00M – $270.00M$220.00M – $240.00MLoweredAug 4, 2026
Adjusted EBITDAnon-GAAPFY2026$70.00M – $80.00M–NewNov 9, 2026
Adjusted EBITDAnon-GAAPFY2026$70.00M – $90.00M$70.00M – $90.00MReaffirmedAug 4, 2026
Modern Oral Gross SalesFY2026$330.00M – $350.00M–NewNov 9, 2026
Modern Oral Gross SalesFY2026$280.00M – $300.00M–NewMay 7, 2026
Modern Oral Net SalesFY2026$210.00M – $225.00M–LoweredMay 7, 2026

Guidance vs results

The last range Turning Point Brands gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q4 FY2021Revenue$93.00M – $103.00M$105.30MAbove range

Guidance history

Every forecast Turning Point Brands put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026Adjusted EBITDAFY2026$70.00M – $80.00MNew
Nov 9, 2026Modern Oral Gross SalesFY2026$330.00M – $350.00MNew
Nov 9, 2026Modern Oral Net SalesFY2026$260.00M – $270.00MNew
Aug 4, 2026Adjusted EBITDAFY2026$70.00M – $90.00MReaffirmed
Aug 4, 2026Modern Oral Net SalesFY2026$260.00M – $270.00MLowered
Aug 4, 2026Modern Oral Gross SalesFY2026$330.00M – $350.00MRaised
May 7, 2026Adjusted EBITDAFY2026$70.00M – $90.00MNew
May 7, 2026Modern Oral Gross SalesFY2026$280.00M – $300.00MNew
May 7, 2026Modern Oral Net SalesFY2026$210.00M – $225.00MLowered
Mar 2, 2026adjusted EBITDAQ1 FY2026$24.00M – $27.00MNew
Mar 2, 2026Modern Oral Gross RevenueFY2026$220.00M – $240.00MNew
Mar 2, 2026Net RevenueFY2026$180.00M – $190.00MLowered
Nov 5, 2025Adjusted EBITDAFY2025$115.00M – $120.00MNew
Nov 5, 2025Modern Oral salesFY2025$125.00M – $130.00MNew
Aug 6, 2025Adjusted EBITDAFY2025$110.00M – $114.00MRaised
Aug 6, 2025Modern Oral salesFY2025$100.00M – $110.00MRaised
May 7, 2025adjusted EBITDAFY2025$108.00M – $113.00MReaffirmed
May 7, 2025Modern Oral salesFY2025$80.00M – $95.00MRaised
Mar 6, 2025adjusted EBITDAFY2025$108.00M – $113.00MNew
Mar 6, 2025combined Modern Oral salesFY2025$60.00M – $80.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Turning Point Brands filed with the SEC as exhibits to Form 8-K or 6-K

  1. Turning Point Brands Announces Third Quarter 2026 Results
    Results
  2. Turning Point Brands Announces Executive Leadership Changes
    Update
  3. Turning Point Brands Announces Second Quarter 2026 Results
    Results
  4. Turning Point Brands Announces First Quarter 2026 Results
    Results
  5. Turning Point Brands Announces Fourth Quarter and Full Year 2025 Results
    Results
  6. Turning Point Brands Announces Third Quarter 2025 Results
    Results
  7. Turning Point Brands Announces Third Quarter 2025 Results
    Results
  8. Turning Point Brands Announces Second Quarter 2025 Results
    Results
  9. Turning Point Brands Announces First Quarter 2025 Results
    Results
  10. Turning Point Brands Announces Fourth Quarter and Full Year 2024 Results
    Results
  11. Turning Point Brands Announces Pricing of $300,000,000 of 7.625% Senior Secured Notes due 2032
    News
  12. Turning Point Brands Announces Third Quarter 2024 Results
    Results
  13. Turning Point Brands Announces Second Quarter 2024 Results
    Results
  14. Turning Point Brands Announces First Quarter 2024 Results
    Results
  15. Turning Point Brands Appoints Andrew Flynn as Chief Financial Officer
    Update

See a number that looks wrong?